Commentary · 21 Feb 2026
Conference abstractPublished 21 Nov 2016
Correlation of prostate specific antigen with metastatic bone disease in prostate cancer on skeletal scintigraphy
Sindh Institute of Urology and Transplantation, Pakistan
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Aim: To evaluate the ability of serum PSA between 2 cutting points considering it as a predictor of bone metastases on bone scan in prostate cancer. Materials & Methods: From Aug to Nov-2013, 42 patients with prostate cancer who underwent bone scan were analyzed. All patients necessarily have a pathological report available. Bony metastases were determined from the bone scan studies and no further correlation with histopathology or other imaging modalities were performed. Results: The mean age, mean PSA and incidence of bone metastasis on bone scan were 68.35 years, 370.51 ng/mL and 19/42 (45.23%), respectively. According to PSA levels, patients were divided into 5 groups <10ng/mL (10/42), 10-20 ng/mL (5/42), 20-50 ng/mL (2/42), 50-100 (3/42), 100-500ng/mL (3/42) and more than 500ng/mL (0/42) presenting negative bone scan. The incidence of positive bone scan (%) for bone metastasis for each group were 01 patient (5.26%), 0%, 03 patients (15.78%), 01 patient (5.26%), 04 patients (21.05%), and 10 patients (52.63%), respectively. Therefore, when the cutting point adopted for PSA serum concentration was 10 ng/mL, a negative predictive value (NPV) for bone metastasis was 95% with sensitivity rates 94.74%; and the PPV and specificity of the method were 56.53% and 43.48%, respectively. When the cutting point of PSA serum concentration was 20 ng/mL the observed results for PPV and specificity were 78.27% and 65.22% respectively, whereas NPV and sensitivity stood 100% and 95% respectively. Conclusion: We concluded that serum PSA concentration of higher than 20 ng/mL was the more accurate cutting point than a serum concentration of PSA higher than 10 ng/mL to predict metastasis on bone scan.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Cancer Science & Therapy.
Perspective · 21 Feb 2026
Finding Potential Passerini Adducts for Anticancer Drug Development
Perspective · 21 Feb 2026
Head and Neck Cutaneous Squamous Cell Carcinoma with Perineural Invasion
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCancer Science & Therapy
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Muhammad Waleed Asfandyar”
- BylineArticles whose byline prints “Akhtar Ahmed”
- BylineArticles whose byline prints “Naureen Nizar”
- BylineArticles whose byline prints “Altaf Hashmi”
- BylineArticles whose byline prints “Anwar Naqvi”
- BylineArticles whose byline prints “Syed Adib-ul-Hasan Rizvi”
